LATEST NEWS
- Research News
Most vaccines include particles called adjuvants. But not all adjuvants are created equal.
- Behind the Science
La Jolla Institute’s “Top Workplaces” ranking proves the power of collaboration in advancing medical research
- Research News
New LJI study shows there may be a way to help even more psoriasis patients
- Research News
New LJI research shows how a range of critical immune cells respond to SARS-CoV-2
- In the News
The international recognition reflects how LJI research is valued by scientific peers
- Research News
ARCS support propels vaccine design and HIV research
- Research News
La Jolla Institute scientists team up with Brigham and Women's Hospital to guide the development of vaccines against the coronavirus family
- Institute News
Richard Stryjewski, a financial leader with deep expertise in the non-profit research sector, has been appointed as Chief Financial Officer at La Jolla Institute for Immunology.
- Immune Matters
Behind every “eureka!” science headline is a story of perseverance
- Immune Matters
See a problem, take action. That’s how she was raised
- Immune Matters
What happened when an LJI scientist revisited a diabetes mystery